hsin-ju ho

* Manufactured and implemented a Phase Ⅲ multicenter, randomized, multiarmed, double-blind, cross-over, efficacy clinical trial data standards (CDISC SDTM), analysis datasets (ADaM), SAS programs and statistical analysis outputs (Tables, Listing and Figures) * Presented 2 Phase III multicenter, randomized, double-blind, efficacy, safety, and tolerability of postoperative pain control clinical trial SAS programs, macros and statistical analysis outputs * Developed 2 Phase Ⅰ multicenter, dose-escalation, safety and pharmacokinetics * for solid tumor clinical trial SAS programs, macros and statistical analysis outputs * Contributed a Phase Ⅱ/III, randomized, multiarmed, double-blind clinical trial to evaluate effectiveness of three products statistical analysis plan (SAP) and table shells

Analyzed over 1300 volunteer demographics and physiological signal from a research project：Non-Invasive Analytical Technology For Blood Glucose, to invent a non -invasive device

* 1. Coordinated research collaboration of hospital physicians and NCU (National * Central University) professors in a research project, managed NCU support of 950,000 TWD (more than 30,000 USD) * 2. Integrated hospital physicians and NCU professors in two research proposals * 3. Coordinated among three different institutions (our hospital, NCU and the HTC Co.) in a globe competition project (XPRIZE, USA, Feb-Apr. 2015), acquired NCU support of 260,000 TWD (almost 8,500 USD) * 4. Advanced hospital physicians apply 4 multinational patents * 5. Managed the serum sample and data of LIONS cohort (Li-Shin Outreach Neighborhood Screening, over 30,000 individual created by our hospital since 2001) * 6. Initiated an international conference in 2014, more than 300 people participants